Regeneron Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$642.14(as of Nov 3, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Regeneron Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$642.14
Ticker SymbolREGN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees15,222
CountyUSA
Market Cap$68,503.8M
EBIDTA4,348.0M
10-Day Moving Average615.85
P/E Ratio15.04
20-Day Moving Average593.54
Forward P/E Ratio15.46
50-Day Moving Average583.03
Earnings per Share41.72
200-Day Moving Average594.86
Profit Margin38.89%
RSI66.71
Shares Outstanding103.3M
ATR20.32
52-Week High840.91
Volume699,841
52-Week Low475.77
Book Value30,957.8M
P/B Ratio2.22
Upper Keltner639.25
P/S Ratio4.83
Lower Keltner547.83
Debt-to-Equity Ratio639.25
Next Earnings Date01/30/2026
Cash Surplus-1,918.7M
Next Ex-Dividend Date11/20/2025
Looking for a prescription for success? Then this could be the stock for you. Regeneron is at the forefront of biotechnology that develops and commercializes life-transforming medicines. They are best known for their blockbuster drug Eylea, which is used to treat age-related macular degeneration—a leading cause of blindness in the elderly.
Regeneron Pharmaceuticals Inc In Our Stock Scanner
As of Nov 04, 2025
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.